drugs in the pipeline will help our ageing population

Pipeline

good pipeline of drug candidates

medical research with stage III drug

JC

speculative/healthcare

Biotech. Betting on their new schitzophrenia drugs to really take off.

Speculative play, but i think they're a great candidate for a buyout

From Barron's 7-23-07:

Market Outperform - Price 13.68 on July 16
by Rodman & Renshaw
Market cap: $504.4 million. "ACAD announced that Allergan will commence an exploratory Phase I clinical study with a small-molecule drug candidate for glaucoma treatment, [trigger[ing] an undisclosed milestone payment to Acadia...The compound emanates from a discovery made at Acadia... clear validation of ACAD's drug-discovery approach. Reiterate Market Outperform; 19 target."

Has promising treatments for schizophrenia and Parkinson's disease and has worked with allergan on a treatment for glaucoma. They want to be in the market with a major player partner.

waiting for re-entry buy point

diotech

speculative play on schizophrenia drug development down in excess of 30%